secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neuphoria Therapeutics Inc. (NEUP)
CIK:        0001191070
Form:       8-K
Filed at:   2025-12-18T23:59:59+00:00
Accession:  0001213900-25-123289
Event type: regulatory
Sentiment:  positive
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Neuphoria Therapeutics regains Nasdaq compliance after holding 2025 annual meeting
--------------------------------------------------------------------------------

- Received Nasdaq deficiency notice on July 18, 2025 for failing to hold annual meeting within 12 months of FY end (Rule 5620(a)).
- Held 2025 annual shareholder meeting on December 12, 2025, satisfying the compliance requirement.
- Nasdaq confirmed on December 18, 2025 that the company has regained compliance; matter is closed.
- Previously disclosed delisting risk related to meeting requirement is now resolved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1191070/000121390025123289/0001213900-25-123289-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1191070/000121390025123289/ea0270248-8k_neuphoria.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-123289

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer